The current liberal regulation of homeopathy in Germany is seen as problematic by most key stakeholders, reflecting a growing consensus that regulatory standards should be tightened. Although homeopathy remains one of the most popular types of alternative medicine in the country, its legal oversight is increasingly debated across the healthcare sector. A qualitative interview study combined with a normative analysis explored how various institutional actors view existing regulatory frameworks.
The regulatory debate surrounding homeopathy in Germany has grown increasingly prominent in recent years, focusing on whether statutory health insurance companies should continue to reimburse these treatments. Prominent players have publicly spoken out in favor of removing reimbursement options offered by statutory health insurers. In contrast, proponents strongly advocate for maintaining continued reimbursement, creating an ongoing national debate over the financial coverage and legal status of alternative therapies.
To investigate stakeholder perspectives on current regulations, researchers carried out semi-structured individual qualitative interviews between March and October 2023. The empirical study gathered insights from 28 participants across multiple sectors of the healthcare landscape. The research team subsequently analyzed the collected interview transcripts using conventional content analysis to examine how different groups interpret regulatory boundaries, reimbursement practices, and professional responsibilities.
The 28 interview participants represented several distinct stakeholder groups involved in German healthcare. These included representatives from statutory health insurance companies, members of German medical associations, and delegates from pharmaceutical associations. The interview cohort also incorporated representatives from State Medical Councils, active homeopathic practitioners, and outspoken critics of homeopathy, providing direct viewpoints from both supportive and critical perspectives within the broader debate.
A key finding emerged regarding the strategic considerations of statutory health insurance companies. Representatives of these health insurers explained that their companies’ incentives to reimburse homeopathy stem mainly from strategic reasons, specifically gaining a competitive advantage in the health insurance market. At the same time, these insurance representatives indicated that they remain skeptical about the actual effectiveness of homeopathy, demonstrating an explicit contrast between competitive market strategy and professional confidence in clinical efficacy.
The interviews also identified a pragmatic acceptance of the use of homeopathy among healthcare professionals, even though confidence in its effectiveness remains low. Alongside these empirical observations, the authors presented a normative analysis arguing that the current liberal regulation of homeopathy in Germany is ethically inappropriate. They conclude that special legal regulations should be removed, asserting that homeopathy should not be treated differently by law and must be held to the same standards as other therapies to create uniformity and equality.
Subject of Research: Stakeholder perspectives and normative analysis of homeopathy regulation in Germany
Article Title: Stakeholder perspectives on the regulation of homeopathy in Germany: a qualitative interview study and normative analysis
Article References: Wagner-Blum, K., Meier, L. J., Rachut, S., Shaw, D., & McLennan, S. (2026). Stakeholder perspectives on the regulation of homeopathy in Germany: a qualitative interview study and normative analysis. BMC Complementary Medicine and Therapies, 26(1), Article 357. https://doi.org/10.1186/s12906-026-05679-7
Image Credits: AI Generated
DOI: 10.1186/s12906-026-05679-7
Keywords: Homeopathy, Germany, Healthcare regulation, Statutory health insurance, Qualitative interviews, Normative analysis, Alternative medicine, Reimbursement policy, Medical associations, Pharmaceutical associations, State Medical Councils, Homeopathic practitioners, Homeopathy critics, Conventional content analysis, Therapy standards, Healthcare ethics
News Source: Ophelia Keating. (November 17, 2026). German Stakeholders Support Tighter Regulation for Homeopathy in Qualitative Interview Study. Scienmag.



